Psoriasis Market is Projected to Grow at a CAGR of 6.09% from 2023-2033 | IMARC Group



Psoriasis Market Report Overview:

Report Attribute

Details

Base Year

2022

Forecast Years

2023-2033

Historical Years

2017-2022

Market Growth (2023-2033)

6.09%

The report offers a comprehensive analysis of the psoriasis market in the United States, EU5 (including Germany, Spain, Italy, France, and the United Kingdom), and Japan. It covers aspects such as treatment methods, drugs available in the market, drugs in development, the proportion of various therapies, and the market's performance in the seven major regions. Additionally, the report evaluates the performance of leading companies and their pharmaceutical products. Current and projected patient numbers across these key markets are also detailed in the report. This study is essential for manufacturers, investors, business planners, researchers, consultants, and anyone interested or involved in the psoriasis market.

Request for a Sample Copy of this Report: 
https://www.imarcgroup.com/psoriasis-market/requestsample

Market Overview:

The 7 major psoriasis markets are expected to exhibit a CAGR of 6.09% during 2023-2033. The primary factor driving the psoriasis market is the increasing incidence of autoimmune disorders, characterized by the faulty attack of the body’s immune system on healthy cells. Along with this, the growing prevalence of various triggering factors, including stress, infections, skin injuries, smoking, and excessive alcohol consumption, is acting as another growth-inducing factor. Additionally, the widespread adoption of topical medications such as corticosteroids, vitamin D analogs, and retinoids that effectively reduce inflammation and provide relief from itching and scaling is bolstering the market growth. Furthermore, the introduction of TNF-alpha and interleukin inhibitors that can alleviate symptoms associated with psoriasis is propelling the market growth. Moreover, the utilization of light therapy, which involves the application of ultraviolet light on the skin to impede the overproduction of skin cells and alleviate itchiness while reducing the size, is contributing to the market growth.

Countries Covered:

• United States
• Germany
• France
• United Kingdom
• Italy
• Spain
• Japan

Analysis Covered Across Each Country:

• Historical, current, and future epidemiology scenario
• Historical, current, and future performance of the psoriasis market
• Historical, current, and future performance of various therapeutic categories in the market
• Sales of various drugs across the psoriasis market
• Reimbursement scenario in the market
• In-market and pipeline drugs

This report also provides a detailed analysis of the current psoriasis marketed drugs and late-stage pipeline drugs.

In-Market Drugs:

• Drug Overview
• Mechanism of Action
• Regulatory Status
• Clinical Trial Results
• Drug Uptake and Market Performance

Late-Stage Pipeline Drugs:

• Drug overview
• Mechanism of action
• Regulatory status
• Clinical trial results
• Drug uptake and market performance

Competitive Landscape With Key Players:

The competitive landscape of the psoriasis market has been studied in the report with the detailed profiles of the key players operating in the market.

Ask Analyst for Customization and Explore Full Report With TOC & List of Figures: https://www.imarcgroup.com/request?type=report&id=7295&flag=C

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Media Contact:

Company Name: IMARC Group

Contact Person: Elena Anderson

Email: sales@imarcgroup.com

Phone: +1-631-791-1145

Address: 134 N 4th St

City: Brooklyn

State: NY

Country: United States

Website: https://www.imarcgroup.com/

Popular posts from this blog

GCC LED Lighting Market Size, Trends, Growth, Forecast & Industry Report 2024-2032

Europe Beer Market Share, Size, Forecast & Analysis 2023-2028

Bulletproof Glass Manufacturing Plant Project Report 2024: Industry Trends, Unit Setup and Machinery